The promise of miRNA replacement therapy for Hepatocellular carcinoma.
CONCLUSION: tumor suppressor miRNAs can act as novel therapeutics for HCC and more studies should be directed toward these promising therapeutics.
PMID: 31657677 [PubMed - as supplied by publisher]
Source: Current Gene Therapy - Category: Genetics & Stem Cells Authors: Elhefnawi M, Salah Z, Soliman B Tags: Curr Gene Ther Source Type: research
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Gene Therapy | Genetics | Hepatocellular Carcinoma | Liver Cancer | Nanotechnology | Study